Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Filtros aplicados
Base de dados
Intervalo de ano de publicação
1.
West Indian med. j ; 49(Supp 2): 32, Apr. 2000.
Artigo em Inglês | MedCarib | ID: med-965

RESUMO

OBJECTIVE: To determine the factors which influence continued use of a family planning method. DESIGN AND METHODS: Primary data were collect from 463 women utilizing the public health services in Kingston, Jamaica. The women were interviewed at six-mon th intervals during one year to determine their patterns of contraceptive use. They were recruited fro eight health centers. RESULTS: The overall continuation rate of the sample of respondents at the end of 3 months, 6 months, 9 months and 12 months were 90 percent, 70 percent, 60 percent and 56 percent, respectively. The short- term method with the highest continuation rate (65 percent) was the injection; the pill registered the lowest continuation rate (39 percent). A respondent was more likely to use a family planning method if her partner was in favour of contraception. She was likely to continue if the method was the condom or the pill. CONCLUSION: The use of the injection should be encouraged in order to improve overall continuation rate. Efforts should be made to include the partner in the counselling of a female client.(AU)


Assuntos
Feminino , Humanos , Dispositivos Anticoncepcionais Femininos , Anticoncepcionais Femininos , Serviços de Planejamento Familiar/métodos , Comportamento Contraceptivo/tendências , Jamaica , Coleta de Dados
2.
Int J Gynaecol Obstet ; 62(Suppl. 1): S31-6, Aug. 1998.
Artigo em Inglês | MedCarib | ID: med-1402

RESUMO

Cyclo-Provera, the original name of the combination of 25 mg medroxyprogesterone acetate and 5 mg estradiol cypionate, later known as Cyclofem and hereafter referred to MPA/E2C, has proven its use- effectiveness (pregnancy rate less than 1 percent) in routine service delivery conditions. Overall, the life-table discontinuation rates at 1 year ranged from 33.5 percent to 71.8 percent. Only a third of total discontinuations were attributable to the injectable contraceptive method, thus raising the importance of service delivery issues related to its continued use. The results of introductory trials in Mexico, Indonesia, Thailand, Tunisia, Jamaica and, more recently, Brazil, Colombia, Chile and Peru have demonstrated that MPA/E2C is a highly effective contraceptive that could be offered as an alternative to current fertility regulation methods for many women around the world. In addition, the results of studies were the basis for the approval of MPA/E2C by local health authorities and its inclusion in the Ministries of Health Family Planning Programs.(Au)


Assuntos
Feminino , Humanos , Anticoncepcionais Femininos , Países em Desenvolvimento , Estradiol/análogos & derivados , Conhecimentos, Atitudes e Prática em Saúde , Acetato de Medroxiprogesterona , Anticoncepcionais Orais Combinados/efeitos adversos , Anticoncepcionais Orais Combinados/química , Preparações de Ação Retardada , Serviços de Planejamento Familiar/métodos , Injeções Intramusculares , Tábuas de Vida , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Gravidez/estatística & dados numéricos , Estudos Prospectivos , Fatores Socioeconômicos , Anticoncepcionais Femininos/efeitos adversos , Anticoncepcionais Femininos/química , Estradiol/efeitos adversos , Estradiol/química
3.
Contraception ; 49(5): 489-507, May 1994.
Artigo em Inglês | MedCarib | ID: med-7155

RESUMO

Studies on the introduction of Cyclofem into family planning programmes have been undertaken in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Cyclofem is a once-a-month injectable contraceptive containing 25mg medroxyprogesterone acetate and 5mg estradiol cypionate. A total of 7927 subjects were followed in close to routine service delivery conditions in primary and secondary family planning outlets. The studies confirmed the high efficacy of the method with 12-month pregnancy rates ranging from 0 to 0.7 percent. Major differences were seen in reasons and rates of discontinuation between countries, the overall 12-month life table discontinuation rates ranging from 33.5 percent in Indonesia to 71.8 percent in Tunisia. The reasons for discontinuation in each of the five countries described, differences between countries contrasted, and service delivery issues which should be addressed further, raised (AU)


Assuntos
Humanos , Feminino , Gravidez , Adolescente , Adulto , Anticoncepcionais Femininos/administração & dosagem , Estradiol/análise , Serviços de Planejamento Familiar , Acetato de Medroxiprogesterona/administração & dosagem , Anticoncepcionais Orais Combinados/administração & dosagem , Anticoncepcionais Orais Combinados/efeitos adversos , Estradiol/administração & dosagem , Estradiol/efeitos adversos , Indonésia , Acetato de Medroxiprogesterona/efeitos adversos , México , Satisfação do Paciente , Projetos Piloto , Gravidez , Tailândia , Tunísia , Organização Mundial da Saúde
6.
Soc Sci Med ; 26(6): 619-23, 1988.
Artigo em Inglês | MedCarib | ID: med-15914

RESUMO

This paper is based on a study of 97 recuits-50 sterilized and 47 non-sterilized--to a family planning programme in Kingston, Jamaica and tries to account for the reluctance of Jamaican women to accept contraceptive sterilization. The study demonstrates the association between mating patterns in the island and the acceptance of sterilization. This irreversible method was more likely to be chosen by women in more stable sexual unions.(AU)


Assuntos
Humanos , Adulto , Feminino , Esterilização Reprodutiva , Mulheres , Anticoncepcionais Femininos/efeitos adversos , Serviços de Planejamento Familiar , Jamaica , Casamento , Paridade , Esterilização Reprodutiva/psicologia , Mulheres/psicologia
7.
Assoc Gen Pract Jamaica Newsl ; 6(1): 6-7, June 1986.
Artigo em Inglês | MedCarib | ID: med-10475

RESUMO

A preliminary report on the use of depo-provera amongst a group of women within childbearing age on an island of the Bahamas shows promise. The duration of administration of the drug in this particular study should be borne in mind when anticipating defaulters (AU)


Assuntos
Humanos , Anticoncepcionais , Anticoncepcionais Femininos , Anticoncepcionais Orais/administração & dosagem , Bahamas
8.
Kingston; Pan American Health Organization; 1984. 15 p.
Monografia em Inglês | MedCarib | ID: med-14148
9.
West Indian med. j;27(4): 196-200, Dec. 1978.
em Inglês | MedCarib | ID: med-10929

RESUMO

Contraceptive continuation in 240 high-risk women was studied over a 24-month period. In the 192 women who actually used contraception, the gross cumulative continuation rate of 27 per 100 women and the pregnancy rate of 38 per 100 women demonstrated that their performance was below that of other reported series. The need for new approaches to the family planning care of these women is indicated (AU)


Assuntos
Adolescente , Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Gravidez , Serviços de Planejamento Familiar , Cooperação do Paciente , Anticoncepcionais Femininos/efeitos adversos , Anticoncepcionais Orais , Gravidez não Desejada , Risco , Barbados
10.
St. Augustine; University of the West Indies (St. Augustine). Institute of Social and Economic Research; 1978. xvi,377 p. tab.
Monografia em Inglês | MedCarib | ID: med-8549
12.
West Indian med. j ; 12(1): 23-7, Mar. 1963.
Artigo em Inglês | MedCarib | ID: med-10608

RESUMO

Some of the problems of family planning among persons of low economic status and limited educational background are discussed. The results of laboratory and clinical tests and field trials of a highly spermicidal foaming liquid and sponge in such a population using the public health services in a rural area in Jamaica, West Indies, are presented. The method was found to be acceptable, practical, and effective. The costs are very low. The usual pregnancy rate in this population is between 70 and 80 per hundred years of woman exposure. Among those using the method the rate dropped to 4.2 pregnancies per hundred exposure years (AU)


Assuntos
Humanos , Adulto , Feminino , Espermicidas/diagnóstico , Espermatozoides/efeitos dos fármacos , Anticoncepcionais Femininos/diagnóstico , Cremes, Espumas e Géis Vaginais/diagnóstico , Anticoncepção/métodos , Serviços de Planejamento Familiar/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA